Frontiers in Aging Neuroscience

Translating blood-based biomarkers into Alzheimer's disease clinical practice: screening, diagnosis, and longitudinal monitoring

By Binbin Xie, Wang Zhang, Yu Zhang, Qiong Li

Figure 1 from Frontiers in Aging Neuroscience — Figure 1. Xie et al.

ReviewBiomarkers

The paper

Binbin Xie, Wang Zhang, Yu Zhang, Qiong Li

Chongqing City Mental Health Center

Frontiers in Aging Neuroscience, 21 Aug 2026

doi.org/10.3389/fnagi.2026.1852137 PubMed 42698737

medRxiv5 Oct 2026
Blood eMTBR-tau linked to Alzheimer’s tangles at autopsy
Neurology4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults
medRxiv7 Oct 2026
Lifestyle trial found similar Alzheimer’s blood marker changes
Annals of Neurology4 Oct 2026
Plasma pTau217 and recall test refine prognosis in Down syndrome